An international trial involving 1,000 volunteers will aim to detect biomarkers associated with the condition.

The trial seeks to find an easier and less expensive way to detect a disease that affects 1 in 9 people over the age of 65.

In many cases, it's not until memory problems start creeping up that most people learn they have Alzheimer's disease. By then, the disease may already be progressing, leaving limited options for ...

While a blood test to look for Alzheimer’s is a monumental leap, and is a great source of hope, we need to remember that a ...

If the new test developed by the research project works, it would be far easier than current scans, lumbar punctures or ...

In patients showing cognitive decline, a new blood test for Alzheimer's is expected to make diagnosis more convenient, accessible and inexpensive than other existing tests. When you purchase through ...

The FDA recently cleared the Lumipulse blood test for early diagnosis of Alzheimer's disease in people 55 and over with memory loss. The noninvasive Lumipulse blood test measures the levels of two ...

Researchers at University College London (UCL) are part of a major international study testing whether a simple finger-prick ...

A blood test made by a Malvern company that can help diagnose Alzheimer's disease, a form of dementia affecting more than 7 million Americans, has been cleared by the U.S. Food and Drug Administration ...

This transcript has been edited for clarity. Hi. I’m Art Caplan. I'm at the Division of Medical Ethics at NYU Grossman School of Medicine in New York City. The FDA recently cleared, for the first time ...

Alzheimer’s disease blood test developer Quanterix put forward new clinical data from its Simoa assay, which it described as the largest population-based assessment of the condition’s ...

The U.S. FDA recently approved a new blood test to diagnose Alzheimer’s disease. The test, called Lumipulse, measures two proteins in plasma: pTau217 and ß-Amyloid 1-42. These proteins clump together ...